Table of Contents
Cholesterol
Volume 2016, Article ID 2048341, 6 pages
http://dx.doi.org/10.1155/2016/2048341
Research Article

In Vivo Antihypercholesterolemic Potential of Swietenia mahagoni Leaf Extract

1Department of Biochemistry, Pooja Bhagavath Memorial Mahajana PG Center, Mysore, India
2Department of Studies in Food Science and Nutrition, University of Mysore, Manasagangothri, Mysore, India

Received 31 July 2016; Revised 15 September 2016; Accepted 18 September 2016

Academic Editor: Patrizia M. Tarugi

Copyright © 2016 Naveen Yelaware Puttaswamy and Asna Urooj. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Durrington, “Dyslipidaemia,” The Lancet, vol. 362, no. 9385, pp. 717–731, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Freedman, “High-fat diets and cardiovascular disease: are nutritional supplements useful?” Journal of the American College of Cardiology, vol. 41, no. 10, pp. 1750–1752, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Jain, R. R. Kulkarni, and D. P. Jain, “Current drug targets for antihyperlipidemic therapy,” Mini-Reviews in Medicinal Chemistry, vol. 10, no. 3, pp. 232–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. N. Levine, J. F. Keaney Jr., and J. A. Vita, “Cholesterol reduction in cardiovascular disease—clinical benefits and possible mechanisms,” The New England Journal of Medicine, vol. 332, no. 8, pp. 512–521, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Ichihashi, M. Izawa, K. Miyata, T. Mizui, K. Hirano, and Y. Takagishi, “Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption,” Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 1, pp. 43–50, 1998. View at Google Scholar · View at Scopus
  6. W. Shi, M. E. Haberland, M.-L. Jien, D. M. Shih, and A. J. Lusis, “Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice,” Circulation, vol. 102, no. 1, pp. 75–81, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. H. N. Ginsberg, “Review: efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 2, pp. 383–392, 2006. View at Google Scholar
  8. Y. P. U. Naveen, G. D. Rupini, F. Ahmed, and A. Urooj, “Pharmacological effects and active phytoconstituents of Swietenia mahagoni: a review,” Journal of Integrative Medicine, vol. 12, no. 2, pp. 86–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Sahgal, S. Ramanathan, S. Sasidharan, M. N. Mordi, S. Ismail, and S. M. Mansor, “Brine shrimp lethality and acute oral toxicity studies on Swietenia mahagoni (Linn.) Jacq. seed methanolic extract,” Pharmacognosy Research, vol. 2, no. 4, pp. 215–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F.-T.-Z. Nadi, “Phytochemical screening, membrane stabilizing activity and cytotoxicity of ethanol extract of swietenia mahagony leaf,” 2015, http://dspace.bracu.ac.bd/jspui/handle/10361/4662
  11. G. Sahgal, S. Ramanathan, S. Sasidharan, M. N. Mordi, S. Ismail, and S. M. Mansor, “In vitro antioxidant and xanthine oxidase inhibitory activities of methanolic Swietenia mahagoni seed extracts,” Molecules, vol. 14, no. 11, pp. 4476–4485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ekimoto, Y. Irie, Y. Araki, G.-Q. Han, S. Kadota, and T. Kikuchi, “Platelet aggregation inhibitors from the seeds of Swietenia mahagoni: inhibition of in vitro and in vivo platelet-activating factor-induced effects of tetranortriterpenoids related to swietenine and swietenolide,” Planta Medica, vol. 57, no. 1, pp. 56–58, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. P. Naveen and A. Urooj, “Phytochemical, proximite composition and antioxidant potential of Swietenia mahagoni leaves,” Asian Journal of Pharmceutical Research, vol. 5, no. 3, pp. 161–166, 2015. View at Google Scholar
  14. Y. P. Naveen and A. Urooj, “Preclinical safety evaluation of Swietenia Mahagoni leaf in wistar rats,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 5, pp. 294–297, 2015. View at Google Scholar · View at Scopus
  15. Y. P. Naveen and A. Urooj, “Amelioration of diabetes by Swietenia mahagoni in streptozotocin induced diabetic rats,” International Journal of Pharmaceutical Sciences and Research, vol. 6, no. 9, p. 3892, 2015. View at Google Scholar
  16. C. Beauchamp and I. Fridovich, “Superoxide dismutase: improved assays and an assay applicable to acrylamide gels,” Analytical Biochemistry, vol. 44, no. 1, pp. 276–287, 1971. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Góth, “A simple method for determination of serum catalase activity and revision of reference range,” Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143–151, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ellman, “A spectrophotometric method for determination of reduced glutathione in tissues,” Analytical Biochemistry, vol. 74, pp. 214–226, 1959. View at Google Scholar
  19. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. A. V. Rzheshevsky, “Fatal ‘triad’: lipotoxicity, oxidative stress, and phenoptosis,” Biochemistry, vol. 78, no. 9, pp. 991–1000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. E. Cross, A. van der Vliet, C. A. O'Neill, S. Louie, and B. Halliwell, “Oxidants, antioxidants, and respiratory tract lining fluids,” Environmental Health Perspectives, vol. 102, no. 10, pp. 185–191, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Steinberg, “Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime,” Nature Medicine, vol. 8, no. 11, pp. 1211–1217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Tanweer, N. Chand, U. Saddique, C. A. Bailey, and R. U. Khan, “Antiparasitic effect of wild rue (Peganum harmala L.) against experimentally induced coccidiosis in broiler chicks,” Parasitology Research, vol. 113, no. 8, pp. 2951–2960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Khoshzaban, F. Ghaffarifar, and H. R. J. Koohsari, “Peganum harmala aqueous and ethanol extracts effects on lesions caused by Leishmania major (MRHO/IR/75/ER) in BALB/c mice,” Jundishapur Journal of Microbiology, vol. 7, no. 7, Article ID e10992, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. P. Guevara, A. Apilado, H. Sakurai, M. Kozuka, and H. Tokuda, “Anti-inflammatory, antimutagenic and antitumor promoting activities of Mahogany seeds, Swietenia macrophylla (Meliaceae),” Philippine Journal of Science, vol. 125, pp. 271–278, 1996. View at Google Scholar
  26. E. Haney, C. Carson, M. Helfand, and M. McDonagh, “Drug class review HMG-CoA reductase inhibitors (Statins) and fixed-dose combination products containing a statin,” Update, 2009, http://s3.amazonaws.com/mwengine2/pubmedhealth/files/pubmedhealth_n_statins09_pdf.pdf